Cargando…
Immune Profile of Blood, Tissue and Peritoneal Fluid: A Comparative Study in High Grade Serous Epithelial Ovarian Cancer Patients at Interval Debulking Surgery
High-grade serous epithelial ovarian carcinoma (HGSOC) is an immunogenic tumor with a unique tumor microenvironment (TME) that extends to the peritoneal cavity. The immunosuppressive nature of TME imposes the major challenge to develop effective treatment options for HGSOC. Interaction of immune cel...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9784879/ https://www.ncbi.nlm.nih.gov/pubmed/36560531 http://dx.doi.org/10.3390/vaccines10122121 |
_version_ | 1784857916717662208 |
---|---|
author | Kumar, Pavan Ranmale, Samruddhi Tongaonkar, Hemant Mania-Pramanik, Jayanti |
author_facet | Kumar, Pavan Ranmale, Samruddhi Tongaonkar, Hemant Mania-Pramanik, Jayanti |
author_sort | Kumar, Pavan |
collection | PubMed |
description | High-grade serous epithelial ovarian carcinoma (HGSOC) is an immunogenic tumor with a unique tumor microenvironment (TME) that extends to the peritoneal cavity. The immunosuppressive nature of TME imposes the major challenge to develop effective treatment options for HGSOC. Interaction of immune cells in TME is an important factor. Hence, a better understanding of immune profile of TME may be required for exploring alternative treatment options. Immune profiling of peritoneal fluid (PF), tumor specimens, and blood were carried out using flowcytometry, ELISA, and Procartaplex immunoassay. The frequency of CD56(Bright)NK cells and expression of functional receptors were reduced in PF. Increased activating NKp46+CD56(Dim)NK cells may indicate differential antitumor response in PF. Functional receptors on NK, NKT-like and T cells were reduced more drastically in tumor specimens. Soluble ligands MIC-B and PVR were reduced, whereas B7-H6 was increased in PF. Dissemination of tumor cells contributes to soluble ligands in PF. A differential cytokine profile was found in serum and PF as IL-2, IL-8, IL-15, IL-27, IFN-γ, and GM-CSF were elevated specifically in PF. In conclusion, the differential immune profile and correlation of soluble parameters and NK cell receptors with chemo response score may add knowledge to understand anti-tumor immune response to develop effective treatment modality. |
format | Online Article Text |
id | pubmed-9784879 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-97848792022-12-24 Immune Profile of Blood, Tissue and Peritoneal Fluid: A Comparative Study in High Grade Serous Epithelial Ovarian Cancer Patients at Interval Debulking Surgery Kumar, Pavan Ranmale, Samruddhi Tongaonkar, Hemant Mania-Pramanik, Jayanti Vaccines (Basel) Article High-grade serous epithelial ovarian carcinoma (HGSOC) is an immunogenic tumor with a unique tumor microenvironment (TME) that extends to the peritoneal cavity. The immunosuppressive nature of TME imposes the major challenge to develop effective treatment options for HGSOC. Interaction of immune cells in TME is an important factor. Hence, a better understanding of immune profile of TME may be required for exploring alternative treatment options. Immune profiling of peritoneal fluid (PF), tumor specimens, and blood were carried out using flowcytometry, ELISA, and Procartaplex immunoassay. The frequency of CD56(Bright)NK cells and expression of functional receptors were reduced in PF. Increased activating NKp46+CD56(Dim)NK cells may indicate differential antitumor response in PF. Functional receptors on NK, NKT-like and T cells were reduced more drastically in tumor specimens. Soluble ligands MIC-B and PVR were reduced, whereas B7-H6 was increased in PF. Dissemination of tumor cells contributes to soluble ligands in PF. A differential cytokine profile was found in serum and PF as IL-2, IL-8, IL-15, IL-27, IFN-γ, and GM-CSF were elevated specifically in PF. In conclusion, the differential immune profile and correlation of soluble parameters and NK cell receptors with chemo response score may add knowledge to understand anti-tumor immune response to develop effective treatment modality. MDPI 2022-12-12 /pmc/articles/PMC9784879/ /pubmed/36560531 http://dx.doi.org/10.3390/vaccines10122121 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Kumar, Pavan Ranmale, Samruddhi Tongaonkar, Hemant Mania-Pramanik, Jayanti Immune Profile of Blood, Tissue and Peritoneal Fluid: A Comparative Study in High Grade Serous Epithelial Ovarian Cancer Patients at Interval Debulking Surgery |
title | Immune Profile of Blood, Tissue and Peritoneal Fluid: A Comparative Study in High Grade Serous Epithelial Ovarian Cancer Patients at Interval Debulking Surgery |
title_full | Immune Profile of Blood, Tissue and Peritoneal Fluid: A Comparative Study in High Grade Serous Epithelial Ovarian Cancer Patients at Interval Debulking Surgery |
title_fullStr | Immune Profile of Blood, Tissue and Peritoneal Fluid: A Comparative Study in High Grade Serous Epithelial Ovarian Cancer Patients at Interval Debulking Surgery |
title_full_unstemmed | Immune Profile of Blood, Tissue and Peritoneal Fluid: A Comparative Study in High Grade Serous Epithelial Ovarian Cancer Patients at Interval Debulking Surgery |
title_short | Immune Profile of Blood, Tissue and Peritoneal Fluid: A Comparative Study in High Grade Serous Epithelial Ovarian Cancer Patients at Interval Debulking Surgery |
title_sort | immune profile of blood, tissue and peritoneal fluid: a comparative study in high grade serous epithelial ovarian cancer patients at interval debulking surgery |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9784879/ https://www.ncbi.nlm.nih.gov/pubmed/36560531 http://dx.doi.org/10.3390/vaccines10122121 |
work_keys_str_mv | AT kumarpavan immuneprofileofbloodtissueandperitonealfluidacomparativestudyinhighgradeserousepithelialovariancancerpatientsatintervaldebulkingsurgery AT ranmalesamruddhi immuneprofileofbloodtissueandperitonealfluidacomparativestudyinhighgradeserousepithelialovariancancerpatientsatintervaldebulkingsurgery AT tongaonkarhemant immuneprofileofbloodtissueandperitonealfluidacomparativestudyinhighgradeserousepithelialovariancancerpatientsatintervaldebulkingsurgery AT maniapramanikjayanti immuneprofileofbloodtissueandperitonealfluidacomparativestudyinhighgradeserousepithelialovariancancerpatientsatintervaldebulkingsurgery |